ANAB
AnaptysBio, Inc.
Phase 2
AI-extracted
dostarlimab
untreated stage II/III dMMR/MSI-H locally advanced rectal cancer
T-minus 86 days
~ Sep 30, 2026
SEC 8-K
verified 13h ago
Countdown card →